Table 5.
No. (%) of subjects |
|||||||
Haplotype | Total | Healthy | TD | OR (95% CI) | Pa | OR (95% CI) | Pb |
CCTGGC | 304 (45.5) | 153 (43.4) | 151 (47.9) | 1.22 (.98–1.52) | .07 | 1.19 (.96–1.46) | .11 |
CCCAGT | 135 (20.2) | 80 (22.7) | 55 (17.3) | 0.69 (.51–.91) | .009 | 0.71 (.54–.94) | .015 |
TCCAAC | 106 (15.9) | 57 (16.2) | 49 (15.6) | 0.93 (.69–1.25) | .62 | 0.95 (.72–1.28) | .76 |
TGCAAC | 69 (10.5) | 37 (10.5) | 32(10.5) | 0.94 (.64–1.39) | .77 | 0.96 (.66–1.39) | .82 |
Other | 53 (7.9) | 25 (6.9) | 28 (8.7) | 1.20 (.77–1.87) | .41 | 1.16 (.76–1.78) | .49 |
NOTE. CI, confidence interval; OR, odds ratio. Underlined alleles represent CD14 -159 (C) and CD -4191 (T), respectively.
Univariate analysis.
Multivariate analysis.